Nalls Sherbakoff Group’s CRISPR Therapeutics CRSP Stock Holding History

Nalls Sherbakoff Group’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$439	Hold
2023 Q3	$318	Hold
2023 Q2	$449	Hold
2023 Q1	$310	Buy